X-134854160-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP7BS2

The NM_001388447.1(PABIR3):​c.756C>T​(p.Ile252Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000852 in 1,208,567 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000081 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000086 ( 0 hom. 37 hem. )

Consequence

PABIR3
NM_001388447.1 synonymous

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.121

Publications

2 publications found
Variant links:
Genes affected
PABIR3 (HGNC:25202): (PABIR family member 3) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06335795).
BP7
Synonymous conserved (PhyloP=0.121 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR3NM_001388447.1 linkc.756C>T p.Ile252Ile synonymous_variant Exon 11 of 11 ENST00000645433.2 NP_001375376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR3ENST00000645433.2 linkc.756C>T p.Ile252Ile synonymous_variant Exon 11 of 11 NM_001388447.1 ENSP00000496338.1 A0A2R8Y7S4

Frequencies

GnomAD3 genomes
AF:
0.0000807
AC:
9
AN:
111554
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000150
Gnomad OTH
AF:
0.000661
GnomAD2 exomes
AF:
0.0000712
AC:
13
AN:
182580
AF XY:
0.0000596
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000723
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000980
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.0000857
AC:
94
AN:
1096961
Hom.:
0
Cov.:
29
AF XY:
0.000102
AC XY:
37
AN XY:
362335
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26372
American (AMR)
AF:
0.000114
AC:
4
AN:
35177
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19371
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30182
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54019
European-Finnish (FIN)
AF:
0.0000989
AC:
4
AN:
40465
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.0000987
AC:
83
AN:
841176
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46065
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000806
AC:
9
AN:
111606
Hom.:
0
Cov.:
23
AF XY:
0.0000592
AC XY:
2
AN XY:
33800
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30723
American (AMR)
AF:
0.00
AC:
0
AN:
10408
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5988
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000150
AC:
8
AN:
53164
Other (OTH)
AF:
0.000653
AC:
1
AN:
1531
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.0000604
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000148
AC:
18
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 10, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.512C>T (p.S171L) alteration is located in exon 7 (coding exon 7) of the FAM122C gene. This alteration results from a C to T substitution at nucleotide position 512, causing the serine (S) at amino acid position 171 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
1.4
DANN
Benign
0.12
DEOGEN2
Benign
0.029
T
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.0024
T
MetaRNN
Benign
0.063
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.69
N
PhyloP100
0.12
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.036
Sift
Pathogenic
0.0
D
Sift4G
Benign
1.0
T
Polyphen
0.35
B
Vest4
0.12
MVP
0.65
MPC
0.14
ClinPred
0.052
T
GERP RS
1.6
Varity_R
0.092
gMVP
0.065
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374792816; hg19: chrX-133988190; COSMIC: COSV66194417; COSMIC: COSV66194417; API